免疫檢查點(diǎn)抑制劑在晚期結(jié)直腸癌治療中的研究進(jìn)展

打開文本圖片集

Research Progress of Immune Checkpoint Inhibitors in the Treatment of Advanced Colorectal Cancer/YIN Jianjian， ZHAO Huarong.//Medical Innovation of China， 2025， 22（10）： 165-169

[Abstract]Colorectal cancer is the most common malignant tumor of the digestive system，the incidence of malignant tumors inthe worldranks thethird，thedeathrate isthesecond， andmostofthediscovery islate，causing agreatthreat tothe life and health ofpatients.The emergenceof immunecheckpoint inhibitorshas brought anew opportunity for systemic treatment of patients withadvanced colorectal cancer， showing a good application prospect， and hasbecome anew therapeuticstrategy.This article aims toreview theresearch status andprogressof immune checkpoint inhibitors in the treatment of advanced colorectal cancer.

[Key words] Immunotherapy Colorectal cancer Immune checkpoint inhibitor：

First-author's address： Department 1， Cancer Center， the First Affiliated Hospital of Xinjiang Iedical University， Urumqi 830ooo， China

doi：10.3969/j.issn.1674-4985.2025.10.039

作為消化系統(tǒng)中常見癌種，結(jié)直腸癌（colorectalcancer，CRC）發(fā)病率和死亡率近年來均呈上升趨勢，根據(jù)全球癌癥統(tǒng)計(jì)數(shù)據(jù)，其發(fā)病率在全球范圍內(nèi)位居惡性腫瘤第三位，死亡率高居第二位。（剩余12840字）